Cutting-Edge Mass Spectrometry Imaging Technology for Oncology Research
22 Apr 2019
From desorption electrospray ionization (DESI) for mass spectrometry imaging, to discovery and targeted omics, accelerate your oncology research with the wide range of analytical technologies for characterizing biomolecular signatures of cancer from Waters Corporation.
This interview was filmed as part of our coverage of AACR 2019 - see other video highlights here >>
Related Products
Request Quote for All Products
Xevo G2-XS QTof
WatersXevo G2-XS QTof - eXtreme Sensitivity, eXtraordinary Selectivity, eXceptional Solutions. For the scientist who needs to identify, quantify and confirm the broadest range of compounds in the most complex and challenging samples the Xevo G2-XS QTof provides maximum robustness with no compromise in performance, class-leading real-world quantitative sensitivity, the highest quality, most comprehensive qualitative information, flexibility to adapt to changing needs and is accessible to experts and non-experts alike.
